Buys | $20,712 | 2 | 100 |
Sells | $0 | 0 | 0 |
Divers Stephen | Chief Medical Officer | 1 | $10,750 | 0 | $0 | $10,750 |
Schonherz Todd | Chief Executive Officer | 1 | $9,962 | 0 | $0 | $9,962 |
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 …
Over the last 12 months, insiders at American Oncology Network, Inc. have bought $20,712 and sold $0 worth of American Oncology Network, Inc. stock.
On average, over the past 5 years, insiders at American Oncology Network, Inc. have bought $20,712 and sold $2.16M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Divers Stephen (Chief Medical Officer) — $10,750. Schonherz Todd (Chief Executive Officer) — $9,962.
The last purchase of 5,000 shares for transaction amount of $10,750 was made by Divers Stephen (Chief Medical Officer) on 2024‑05‑24.
2024-05-24 | Divers Stephen | Chief Medical Officer | 5,000 0.0059% | $2.15 | $10,750 | +69.25% | ||
2024-05-21 | Schonherz Todd | Chief Executive Officer | 5,340 0.0055% | $1.87 | $9,962 | +111.76% | ||
2023-09-25 | Sale | Saba Capital Management, L.P. | 10 percent owner | 205,512 1.1821% | $10.50 | $2.16M | -69.69% |
Increased Positions | <1 | company.increased | <1 | company.increased |
Decreased Positions | <1 | company.decreased | <1 | company.decreased |
New Positions | <1 | New | <1 | New |
Sold Out Positions | <1 | Sold Out | <1 | Sold Out |
Total Postitions | <1 | company.total | <1 | company.total |